Page 2 - index
P. 2

Continued from page 01

                         Position the Laboratory

                   for Molecular Testing NOW

        Four factors will drive the                               What are the advantages
        continued growth of MDx testing:                          of MDx testing?

        REIMBURSEMENT RESOLUTION     CLEAR FDA GUIDANCE           Molecular genetics has progressed since 2002 and is no
        regulating CPT codes for     proposing new policies       longer restricted to academic or reference laboratory settings.
        proper reimbursement         and regulations              Hospitals doing MDx testing are profiting from in-house testing
                                                                  and are enjoying the benefits of faster turnaround times, greater
        PHARMACOGENOMICS             POINT-OF-CARE TESTING        and improved sensitivities, accuracy, and cost savings from not
        continuing the market trend   advancing next-generation   sending out to reference laboratories.
        with genetics discoveries    technology for genetic testing  Technology will continue to drive this industry.
                                                                  Those who wait will be at a disadvantage.

          RCM Enterprise Services, Inc. | A Revenue Cycle Management Company
   1   2   3   4   5   6   7